Global and Japan Fexofenadine Market Insights, Forecast to 2027

SKU ID :QYR-18924683 | Published Date: 17-Aug-2021 | No. of pages: 158
1 Study Coverage 1.1 Fexofenadine Product Introduction 1.2 Market by Type 1.2.1 Global Fexofenadine Market Size Growth Rate by Type 1.2.2 Purity:98% 1.2.3 Purity:Above 98% 1.3 Market by Application 1.3.1 Global Fexofenadine Market Size Growth Rate by Application 1.3.2 Hay Fever Treatment 1.3.3 Urticaria Treatment 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Fexofenadine Market Size, Estimates and Forecasts 2.1.1 Global Fexofenadine Revenue 2016-2027 2.1.2 Global Fexofenadine Sales 2016-2027 2.2 Global Fexofenadine, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Fexofenadine Historical Market Size by Region (2016-2021) 2.3.1 Global Fexofenadine Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Fexofenadine Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Fexofenadine Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Fexofenadine Sales Forecast by Region (2022-2027) 2.4.2 Global Fexofenadine Revenue Forecast by Region (2022-2027) 3 Global Fexofenadine Competitor Landscape by Players 3.1 Global Top Fexofenadine Manufacturers by Sales 3.1.1 Global Fexofenadine Sales by Manufacturer (2016-2021) 3.1.2 Global Fexofenadine Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Fexofenadine Manufacturers by Revenue 3.2.1 Key Fexofenadine Manufacturers Covered: Ranking by Revenue 3.2.2 Global Fexofenadine Revenue by Manufacturers (2016-2021) 3.2.3 Global Fexofenadine Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Fexofenadine Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Fexofenadine Revenue in 2020 3.2.6 Global Fexofenadine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Fexofenadine Price by Manufacturers 3.4 Global Fexofenadine Manufacturing Base Distribution, Product Types 3.4.1 Fexofenadine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Fexofenadine Product Type 3.4.3 Date of International Manufacturers Enter into Fexofenadine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Fexofenadine Market Size by Type (2016-2021) 4.1.1 Global Fexofenadine Sales by Type (2016-2021) 4.1.2 Global Fexofenadine Revenue by Type (2016-2021) 4.1.3 Fexofenadine Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Fexofenadine Market Size Forecast by Type (2022-2027) 4.2.1 Global Fexofenadine Sales Forecast by Type (2022-2027) 4.2.2 Global Fexofenadine Revenue Forecast by Type (2022-2027) 4.2.3 Fexofenadine Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Fexofenadine Market Size by Application (2016-2021) 5.1.1 Global Fexofenadine Sales by Application (2016-2021) 5.1.2 Global Fexofenadine Revenue by Application (2016-2021) 5.1.3 Fexofenadine Price by Application (2016-2021) 5.2 Fexofenadine Market Size Forecast by Application (2022-2027) 5.2.1 Global Fexofenadine Sales Forecast by Application (2022-2027) 5.2.2 Global Fexofenadine Revenue Forecast by Application (2022-2027) 5.2.3 Global Fexofenadine Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Fexofenadine Market Size YoY Growth 2016-2027 6.1.1 Japan Fexofenadine Sales YoY Growth 2016-2027 6.1.2 Japan Fexofenadine Revenue YoY Growth 2016-2027 6.1.3 Japan Fexofenadine Market Share in Global Market 2016-2027 6.2 Japan Fexofenadine Market Size by Players (International and Local Players) 6.2.1 Japan Top Fexofenadine Players by Sales (2016-2021) 6.2.2 Japan Top Fexofenadine Players by Revenue (2016-2021) 6.3 Japan Fexofenadine Historic Market Review by Type (2016-2021) 6.3.1 Japan Fexofenadine Sales Market Share by Type (2016-2021) 6.3.2 Japan Fexofenadine Revenue Market Share by Type (2016-2021) 6.3.3 Japan Fexofenadine Price by Type (2016-2021) 6.4 Japan Fexofenadine Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Fexofenadine Sales Forecast by Type (2022-2027) 6.4.2 Japan Fexofenadine Revenue Forecast by Type (2022-2027) 6.4.3 Japan Fexofenadine Price Forecast by Type (2022-2027) 6.5 Japan Fexofenadine Historic Market Review by Application (2016-2021) 6.5.1 Japan Fexofenadine Sales Market Share by Application (2016-2021) 6.5.2 Japan Fexofenadine Revenue Market Share by Application (2016-2021) 6.5.3 Japan Fexofenadine Price by Application (2016-2021) 6.6 Japan Fexofenadine Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Fexofenadine Sales Forecast by Application (2022-2027) 6.6.2 Japan Fexofenadine Revenue Forecast by Application (2022-2027) 6.6.3 Japan Fexofenadine Price Forecast by Application (2022-2027) 7 North America 7.1 North America Fexofenadine Market Size YoY Growth 2016-2027 7.2 North America Fexofenadine Market Facts & Figures by Country 7.2.1 North America Fexofenadine Sales by Country (2016-2021) 7.2.2 North America Fexofenadine Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Fexofenadine Market Size YoY Growth 2016-2027 8.2 Asia Pacific Fexofenadine Market Facts & Figures by Region 8.2.1 Asia Pacific Fexofenadine Sales by Region (2016-2021) 8.2.2 Asia Pacific Fexofenadine Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 9 Europe 9.1 Europe Fexofenadine Market Size YoY Growth 2016-2027 9.2 Europe Fexofenadine Market Facts & Figures by Country 9.2.1 Europe Fexofenadine Sales by Country (2016-2021) 9.2.2 Europe Fexofenadine Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Fexofenadine Market Size YoY Growth 2016-2027 10.2 Latin America Fexofenadine Market Facts & Figures by Country 10.2.1 Latin America Fexofenadine Sales by Country (2016-2021) 10.2.2 Latin America Fexofenadine Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Fexofenadine Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Fexofenadine Market Facts & Figures by Country 11.2.1 Middle East and Africa Fexofenadine Sales by Country (2016-2021) 11.2.2 Middle East and Africa Fexofenadine Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Viruj Pharma 12.1.1 Viruj Pharma Corporation Information 12.1.2 Viruj Pharma Description and Business Overview 12.1.3 Viruj Pharma Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Viruj Pharma Fexofenadine Products Offered 12.1.5 Viruj Pharma Recent Development 12.2 Cemex Pharma 12.2.1 Cemex Pharma Corporation Information 12.2.2 Cemex Pharma Description and Business Overview 12.2.3 Cemex Pharma Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Cemex Pharma Fexofenadine Products Offered 12.2.5 Cemex Pharma Recent Development 12.3 Smaart Pharmaceutticals 12.3.1 Smaart Pharmaceutticals Corporation Information 12.3.2 Smaart Pharmaceutticals Description and Business Overview 12.3.3 Smaart Pharmaceutticals Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Smaart Pharmaceutticals Fexofenadine Products Offered 12.3.5 Smaart Pharmaceutticals Recent Development 12.4 Titan Pharma 12.4.1 Titan Pharma Corporation Information 12.4.2 Titan Pharma Description and Business Overview 12.4.3 Titan Pharma Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Titan Pharma Fexofenadine Products Offered 12.4.5 Titan Pharma Recent Development 12.5 AFCL 12.5.1 AFCL Corporation Information 12.5.2 AFCL Description and Business Overview 12.5.3 AFCL Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.5.4 AFCL Fexofenadine Products Offered 12.5.5 AFCL Recent Development 12.6 Synkromax 12.6.1 Synkromax Corporation Information 12.6.2 Synkromax Description and Business Overview 12.6.3 Synkromax Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Synkromax Fexofenadine Products Offered 12.6.5 Synkromax Recent Development 12.7 Farmhispania 12.7.1 Farmhispania Corporation Information 12.7.2 Farmhispania Description and Business Overview 12.7.3 Farmhispania Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Farmhispania Fexofenadine Products Offered 12.7.5 Farmhispania Recent Development 12.8 Gen Pharma 12.8.1 Gen Pharma Corporation Information 12.8.2 Gen Pharma Description and Business Overview 12.8.3 Gen Pharma Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Gen Pharma Fexofenadine Products Offered 12.8.5 Gen Pharma Recent Development 12.9 Admiron Life Sciences Private Limited 12.9.1 Admiron Life Sciences Private Limited Corporation Information 12.9.2 Admiron Life Sciences Private Limited Description and Business Overview 12.9.3 Admiron Life Sciences Private Limited Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Admiron Life Sciences Private Limited Fexofenadine Products Offered 12.9.5 Admiron Life Sciences Private Limited Recent Development 12.10 JRC 12.10.1 JRC Corporation Information 12.10.2 JRC Description and Business Overview 12.10.3 JRC Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.10.4 JRC Fexofenadine Products Offered 12.10.5 JRC Recent Development 12.11 Viruj Pharma 12.11.1 Viruj Pharma Corporation Information 12.11.2 Viruj Pharma Description and Business Overview 12.11.3 Viruj Pharma Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Viruj Pharma Fexofenadine Products Offered 12.11.5 Viruj Pharma Recent Development 12.12 Sibram 12.12.1 Sibram Corporation Information 12.12.2 Sibram Description and Business Overview 12.12.3 Sibram Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Sibram Products Offered 12.12.5 Sibram Recent Development 12.13 Sumitomo Chemical 12.13.1 Sumitomo Chemical Corporation Information 12.13.2 Sumitomo Chemical Description and Business Overview 12.13.3 Sumitomo Chemical Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Sumitomo Chemical Products Offered 12.13.5 Sumitomo Chemical Recent Development 12.14 Panchsheel 12.14.1 Panchsheel Corporation Information 12.14.2 Panchsheel Description and Business Overview 12.14.3 Panchsheel Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Panchsheel Products Offered 12.14.5 Panchsheel Recent Development 12.15 CAMEO HEALTH CARE 12.15.1 CAMEO HEALTH CARE Corporation Information 12.15.2 CAMEO HEALTH CARE Description and Business Overview 12.15.3 CAMEO HEALTH CARE Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.15.4 CAMEO HEALTH CARE Products Offered 12.15.5 CAMEO HEALTH CARE Recent Development 12.16 CEPiA-Sanofi 12.16.1 CEPiA-Sanofi Corporation Information 12.16.2 CEPiA-Sanofi Description and Business Overview 12.16.3 CEPiA-Sanofi Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.16.4 CEPiA-Sanofi Products Offered 12.16.5 CEPiA-Sanofi Recent Development 12.17 Va Sudha Pharma Chem Limited 12.17.1 Va Sudha Pharma Chem Limited Corporation Information 12.17.2 Va Sudha Pharma Chem Limited Description and Business Overview 12.17.3 Va Sudha Pharma Chem Limited Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Va Sudha Pharma Chem Limited Products Offered 12.17.5 Va Sudha Pharma Chem Limited Recent Development 12.18 VPL Chemicals 12.18.1 VPL Chemicals Corporation Information 12.18.2 VPL Chemicals Description and Business Overview 12.18.3 VPL Chemicals Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.18.4 VPL Chemicals Products Offered 12.18.5 VPL Chemicals Recent Development 12.19 Zhejiang Excel Pharmaceutical 12.19.1 Zhejiang Excel Pharmaceutical Corporation Information 12.19.2 Zhejiang Excel Pharmaceutical Description and Business Overview 12.19.3 Zhejiang Excel Pharmaceutical Fexofenadine Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Zhejiang Excel Pharmaceutical Products Offered 12.19.5 Zhejiang Excel Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Fexofenadine Industry Trends 13.2 Fexofenadine Market Drivers 13.3 Fexofenadine Market Challenges 13.4 Fexofenadine Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Fexofenadine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
List of Tables Table 1. Global Fexofenadine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Purity:98% Table 3. Major Manufacturers of Purity:Above 98% Table 4. Global Fexofenadine Market Size Growth Rate by Application (2021-2027) & (MT) Table 5. Global Fexofenadine Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Fexofenadine Sales by Regions (2016-2021) & (MT) Table 7. Global Fexofenadine Sales Market Share by Regions (2016-2021) Table 8. Global Fexofenadine Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Fexofenadine Sales Forecast by Region (2022-2027) & (MT) Table 10. Global Fexofenadine Sales Market Share Forecast by Region (2022-2027) Table 11. Global Fexofenadine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Fexofenadine Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Fexofenadine Sales by Manufacturers (2016-2021) (MT) Table 14. Global Fexofenadine Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Fexofenadine Manufacturers by Revenue (US$ Million) in 2020 Table 16. Fexofenadine Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Fexofenadine Revenue Share by Manufacturers (2016-2021) Table 18. Global Fexofenadine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Fexofenadine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fexofenadine as of 2020) Table 20. Key Manufacturers Fexofenadine Price (2016-2021) (USD/MT) Table 21. Fexofenadine Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Fexofenadine Product Type Table 23. Date of International Manufacturers Enter into Fexofenadine Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Fexofenadine Sales by Type (2016-2021) (MT) Table 26. Global Fexofenadine Sales Share by Type (2016-2021) Table 27. Global Fexofenadine Revenue by Type (2016-2021) (US$ Million) Table 28. Global Fexofenadine Revenue Share by Type (2016-2021) Table 29. Fexofenadine Average Selling Price (ASP) by Type (2016-2021) & (USD/MT) Table 30. Global Fexofenadine Sales Forecast by Type (2022-2027) & (MT) Table 31. Global Fexofenadine Sales Market Share Forecast by Type (2022-2027) Table 32. Global Fexofenadine Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Fexofenadine Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Fexofenadine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT) Table 35. Global Fexofenadine Sales by Application (2016-2021) (MT) Table 36. Global Fexofenadine Sales Share by Application (2016-2021) Table 37. Global Fexofenadine Revenue by Application (2016-2021) (US$ Million) Table 38. Global Fexofenadine Revenue Share by Application (2016-2021) Table 39. Fexofenadine Average Selling Price (ASP) by Application (2016-2021) & (USD/MT) Table 40. Global Fexofenadine Sales Forecast by Application (2022-2027) & (MT) Table 41. Global Fexofenadine Sales Market Share Forecast by Application (2022-2027) Table 42. Global Fexofenadine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Fexofenadine Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Fexofenadine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT) Table 45. Japan Fexofenadine Sales (MT) of Key Companies (2016-2021) Table 46. Japan Fexofenadine Sales Share by Company (2016-2021) Table 47. Japan Fexofenadine Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Fexofenadine Revenue Share by Company (2016-2021) Table 49. Japan Fexofenadine Sales (MT) by Type (2016-2021) Table 50. Japan Fexofenadine Sales Share by Type (2016-2021) Table 51. Japan Fexofenadine Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Fexofenadine Price (USD/MT) by Type (2016-2021) Table 53. Japan Fexofenadine Sales (MT) by Type (2022-2027) Table 54. Japan Fexofenadine Sales Share by Type (2022-2027) Table 55. Japan Fexofenadine Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Fexofenadine Revenue Share by Type (2022-2027) Table 57. Japan Fexofenadine Price (USD/MT) by Type (2022-2027) Table 58. Japan Fexofenadine Sales (MT) by Application (2016-2021) Table 59. Japan Fexofenadine Sales Share by Application (2016-2021) Table 60. Japan Fexofenadine Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Fexofenadine Price (USD/MT) by Application (2016-2021) Table 62. Japan Fexofenadine Sales (MT) by Application (2022-2027) Table 63. Japan Fexofenadine Sales Share by Application (2022-2027) Table 64. Japan Fexofenadine Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Fexofenadine Revenue Share by Application (2022-2027) Table 66. Japan Fexofenadine Price (USD/MT) by Application (2022-2027) Table 67. North America Fexofenadine Sales by Country (2016-2021) & (MT) Table 68. North America Fexofenadine Sales Market Share by Country (2016-2021) Table 69. North America Fexofenadine Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Fexofenadine Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Fexofenadine Sales by Region (2016-2021) & (MT) Table 72. Asia Pacific Fexofenadine Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Fexofenadine Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Fexofenadine Revenue Market Share by Region (2016-2021) Table 75. Europe Fexofenadine Sales by Country (2016-2021) & (MT) Table 76. Europe Fexofenadine Sales Market Share by Country (2016-2021) Table 77. Europe Fexofenadine Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Fexofenadine Revenue Market Share by Country (2016-2021) Table 79. Latin America Fexofenadine Sales by Country (2016-2021) & (MT) Table 80. Latin America Fexofenadine Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Fexofenadine Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Fexofenadine Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Fexofenadine Sales by Country (2016-2021) & (MT) Table 84. Middle East and Africa Fexofenadine Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Fexofenadine Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Fexofenadine Revenue Market Share by Country (2016-2021) Table 87. Viruj Pharma Corporation Information Table 88. Viruj Pharma Description and Business Overview Table 89. Viruj Pharma Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 90. Viruj Pharma Fexofenadine Product Table 91. Viruj Pharma Recent Development Table 92. Cemex Pharma Corporation Information Table 93. Cemex Pharma Description and Business Overview Table 94. Cemex Pharma Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 95. Cemex Pharma Product Table 96. Cemex Pharma Recent Development Table 97. Smaart Pharmaceutticals Corporation Information Table 98. Smaart Pharmaceutticals Description and Business Overview Table 99. Smaart Pharmaceutticals Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 100. Smaart Pharmaceutticals Product Table 101. Smaart Pharmaceutticals Recent Development Table 102. Titan Pharma Corporation Information Table 103. Titan Pharma Description and Business Overview Table 104. Titan Pharma Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 105. Titan Pharma Product Table 106. Titan Pharma Recent Development Table 107. AFCL Corporation Information Table 108. AFCL Description and Business Overview Table 109. AFCL Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 110. AFCL Product Table 111. AFCL Recent Development Table 112. Synkromax Corporation Information Table 113. Synkromax Description and Business Overview Table 114. Synkromax Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 115. Synkromax Product Table 116. Synkromax Recent Development Table 117. Farmhispania Corporation Information Table 118. Farmhispania Description and Business Overview Table 119. Farmhispania Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 120. Farmhispania Product Table 121. Farmhispania Recent Development Table 122. Gen Pharma Corporation Information Table 123. Gen Pharma Description and Business Overview Table 124. Gen Pharma Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 125. Gen Pharma Product Table 126. Gen Pharma Recent Development Table 127. Admiron Life Sciences Private Limited Corporation Information Table 128. Admiron Life Sciences Private Limited Description and Business Overview Table 129. Admiron Life Sciences Private Limited Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 130. Admiron Life Sciences Private Limited Product Table 131. Admiron Life Sciences Private Limited Recent Development Table 132. JRC Corporation Information Table 133. JRC Description and Business Overview Table 134. JRC Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 135. JRC Product Table 136. JRC Recent Development Table 137. Archerchem Corporation Information Table 138. Archerchem Description and Business Overview Table 139. Archerchem Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 140. Archerchem Product Table 141. Archerchem Recent Development Table 142. Sibram Corporation Information Table 143. Sibram Description and Business Overview Table 144. Sibram Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 145. Sibram Product Table 146. Sibram Recent Development Table 147. Sumitomo Chemical Corporation Information Table 148. Sumitomo Chemical Description and Business Overview Table 149. Sumitomo Chemical Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 150. Sumitomo Chemical Product Table 151. Sumitomo Chemical Recent Development Table 152. Panchsheel Corporation Information Table 153. Panchsheel Description and Business Overview Table 154. Panchsheel Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 155. Panchsheel Product Table 156. Panchsheel Recent Development Table 157. CAMEO HEALTH CARE Corporation Information Table 158. CAMEO HEALTH CARE Description and Business Overview Table 159. CAMEO HEALTH CARE Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 160. CAMEO HEALTH CARE Product Table 161. CAMEO HEALTH CARE Recent Development Table 162. CEPiA-Sanofi Corporation Information Table 163. CEPiA-Sanofi Description and Business Overview Table 164. CEPiA-Sanofi Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 165. CEPiA-Sanofi Product Table 166. CEPiA-Sanofi Recent Development Table 167. Va Sudha Pharma Chem Limited Corporation Information Table 168. Va Sudha Pharma Chem Limited Description and Business Overview Table 169. Va Sudha Pharma Chem Limited Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 170. Va Sudha Pharma Chem Limited Product Table 171. Va Sudha Pharma Chem Limited Recent Development Table 172. VPL Chemicals Corporation Information Table 173. VPL Chemicals Description and Business Overview Table 174. VPL Chemicals Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 175. VPL Chemicals Product Table 176. VPL Chemicals Recent Development Table 177. Zhejiang Excel Pharmaceutical Corporation Information Table 178. Zhejiang Excel Pharmaceutical Description and Business Overview Table 179. Zhejiang Excel Pharmaceutical Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 180. Zhejiang Excel Pharmaceutical Product Table 181. Zhejiang Excel Pharmaceutical Recent Development Table 182. Fexofenadine Market Trends Table 183. Fexofenadine Market Drivers Table 184. Fexofenadine Market Challenges Table 185. Fexofenadine Market Restraints Table 186. Fexofenadine Customers List Table 187. Fexofenadine Distributors List Table 188. Research Programs/Design for This Report Table 189. Key Data Information from Secondary Sources Table 190. Key Data Information from Primary Sources List of Figures Figure 1. Fexofenadine Product Picture Figure 2. Global Fexofenadine Sales Market Share by Type in 2020 & 2027 Figure 3. Purity:98% Product Picture Figure 4. Purity:Above 98% Product Picture Figure 5. Global Fexofenadine Sales Market Share by Application in 2020 & 2027 Figure 6. Hay Fever Treatment Figure 7. Urticaria Treatment Figure 8. Fexofenadine Report Years Considered Figure 9. Global Fexofenadine Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Fexofenadine Market Size 2016-2027 (US$ Million) Figure 11. Global Fexofenadine Sales 2016-2027 (MT) Figure 12. Global Fexofenadine Market Size Market Share by Region: 2021 Versus 2027 Figure 13. Global Fexofenadine Sales Market Share by Region (2016-2021) Figure 14. Global Fexofenadine Sales Market Share by Region in 2020 Figure 15. Global Fexofenadine Revenue Market Share by Region (2016-2021) Figure 16. Global Fexofenadine Revenue Market Share by Region in 2020 Figure 17. Global Fexofenadine Sales Share by Manufacturer in 2020 Figure 18. The Top 10 and 5 Players Market Share by Fexofenadine Revenue in 2020 Figure 19. Fexofenadine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Fexofenadine Sales Market Share by Type (2016-2021) Figure 21. Global Fexofenadine Sales Market Share by Type in 2020 Figure 22. Global Fexofenadine Revenue Market Share by Type (2016-2021) Figure 23. Global Fexofenadine Revenue Market Share by Type in 2020 Figure 24. Global Fexofenadine Sales Market Share by Application (2016-2021) Figure 25. Global Fexofenadine Sales Market Share by Application in 2020 Figure 26. Global Fexofenadine Revenue Market Share by Application (2016-2021) Figure 27. Global Fexofenadine Revenue Market Share by Application in 2020 Figure 28. Japan Fexofenadine Sales Growth Rate 2016-2027 (MT) Figure 29. Japan Fexofenadine Revenue Growth Rate 2016-2027 (US$ Million) Figure 30. Japan Fexofenadine Market Share in Global Market 2016-2027 Figure 31. Japan 5 and 10 Largest Fexofenadine Players Market Share by Revenue in Fexofenadine in 2020 Figure 32. Japan Fexofenadine Revenue Share by Type (2016-2021) Figure 33. Japan Fexofenadine Revenue Growth Rate by Type in 2016 & 2020 Figure 34. Japan Fexofenadine Revenue Share by Application (2016-2021) Figure 35. Japan Fexofenadine Revenue Growth Rate by Application in 2016 & 2020 Figure 36. North America Fexofenadine Sales Growth Rate 2016-2021 (MT) Figure 37. North America Fexofenadine Revenue Growth Rate 2016-2021 (US$ Million) Figure 38. North America Fexofenadine Sales Market Share by Country in 2020 Figure 39. North America Fexofenadine Revenue Market Share by Country in 2020 Figure 40. U.S. Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 41. U.S. Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Canada Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 43. Canada Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Europe Fexofenadine Sales Growth Rate 2016-2021 (MT) Figure 45. Europe Fexofenadine Revenue Growth Rate 2016-2021 (US$ Million) Figure 46. Europe Fexofenadine Sales Market Share by Country in 2020 Figure 47. Europe Fexofenadine Revenue Market Share by Country in 2020 Figure 48. Germany Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 49. Germany Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. France Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 51. France Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. U.K. Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 53. U.K. Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. Italy Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 55. Italy Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Russia Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 57. Russia Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Asia Pacific Fexofenadine Sales Growth Rate 2016-2021 (MT) Figure 59. Asia Pacific Fexofenadine Revenue Growth Rate 2016-2021 (US$ Million) Figure 60. Asia Pacific Fexofenadine Sales Market Share by Region in 2020 Figure 61. Asia Pacific Fexofenadine Revenue Market Share by Region in 2020 Figure 62. China Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 63. China Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Japan Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 65. Japan Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. South Korea Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 67. South Korea Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. India Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 69. India Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. Australia Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 71. Australia Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. China Taiwan Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 73. China Taiwan Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Indonesia Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 75. Indonesia Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Thailand Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 77. Thailand Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Malaysia Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 79. Malaysia Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Latin America Fexofenadine Sales Growth Rate 2016-2021 (MT) Figure 81. Latin America Fexofenadine Revenue Growth Rate 2016-2021 (US$ Million) Figure 82. Latin America Fexofenadine Sales Market Share by Country in 2020 Figure 83. Latin America Fexofenadine Revenue Market Share by Country in 2020 Figure 84. Mexico Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 85. Mexico Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Brazil Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 87. Brazil Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 88. Argentina Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 89. Argentina Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Middle East and Africa Fexofenadine Sales Growth Rate 2016-2021 (MT) Figure 91. Middle East and Africa Fexofenadine Revenue Growth Rate 2016-2021 (US$ Million) Figure 92. Middle East and Africa Fexofenadine Sales Market Share by Country in 2020 Figure 93. Middle East and Africa Fexofenadine Revenue Market Share by Country in 2020 Figure 94. Turkey Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 95. Turkey Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Saudi Arabia Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 97. Saudi Arabia Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 98. UAE Fexofenadine Sales Growth Rate (2016-2021) (MT) Figure 99. UAE Fexofenadine Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Fexofenadine Value Chain Figure 101. Channels of Distribution Figure 102. Distributors Profiles Figure 103. Bottom-up and Top-down Approaches for This Report Figure 104. Data Triangulation Figure 105. Key Executives Interviewed
Viruj Pharma Cemex Pharma Smaart Pharmaceutticals Titan Pharma AFCL Synkromax Farmhispania Gen Pharma Admiron Life Sciences Private Limited JRC Archerchem Sibram Sumitomo Chemical Panchsheel CAMEO HEALTH CARE CEPiA-Sanofi Va Sudha Pharma Chem Limited VPL Chemicals Zhejiang Excel Pharmaceutical
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients